AI-generated summary
The authors studied whether near-infrared light at 670 nm, delivered by an implanted optical fiber to the midbrain, could reduce signs and protect brain cells in a monkey model of Parkinson disease induced by MPTP. Monkeys receiving the light showed much less clinical and behavioral impairment than untreated MPTP monkeys, and the light was reported as neuroprotective for dopamine cells. The sample was small, with 11 MPTP and 9 MPTP-NIr monkeys.
- Who or what was studied
- Macaque monkeys in a subacute MPTP model of Parkinson disease (11 MPTP-only and 9 MPTP plus near-infrared light)
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study used a small number of animals in an animal model, and the abstract notes that some monkeys had fiber blockage by hematic fluid, which likely limited light exposure.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.